Corticotropin releasing hormone and the skin

Cotricotropin- releasing hormone ( CRH) and related peptides are produced in skin that is dependent on species and anatomical location. Local peptide production is regulated by ultraviolet radiation ( UVR), glucocorticoids and phase of the hair cycle. The skin also expresses the corresponding receptors ( CRH- R1 and CRH- R2), with CRH- R1 being the major receptor in humans. CRH- R1 is expressed in epidermal and dermal compartments, and CRH- R2 predominantly in dermal structures. The gene coding for CRH- R1 generates multiple isoforms through a process modulated by UVR, cyclic adenosine monophosphate ( cAMP) and phorbol 12- myristate 13-acetate. The phenotypic effects of CRH in human skin cells are largely mediated by CRH- R1alpha through increases in concentrations of cAMP, inositol triphosphate ( IP3), or Ca2+ with subsequent activation of protein kinases A ( PKA) and C ( PKC) dependent pathways. CRH also modulates the activity of nuclear factor of kappa light polypeptide gene enhancer in B- cells ( NF- kappaB), activator protein 1 ( AP-1) and cAMP responsive element binding protein ( CREB). The cellular functions affected by CRH depend on cell type and nutritional status and include modulation of differentiation program( s), proliferation, viability and immune activity. The accumulated evidence indicates that cutaneous CRH is also a component of a local structure organized similarly to the hypothalamo- pituitary- adrenal axis.